Videos

Dr. Ben Casella muses on COVID-19 and vaccine

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Benjamin P. Casella, OD, FAAO,Brooke Henson, Editor

February 27th 2021

Join the conversation

Celebrate World Glaucoma Week March 7-13, 2021

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

February 26th 2021

Glaucoma reminders for ODs during World Glaucoma Week

Optometry Times® news summary 2/28/2021

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director

February 26th 2021

Optometry news updates

Looking ahead to 2021 optometry meetings

February 5th 2021

Optometry Times® news summary 2/7/2021

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

February 5th 2021

Optometry news updates

Optometry Times® news summary 1/17/2021

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

January 17th 2021

Optometry news updates

Alliance for Patient Safety chair talks contact lenses and the FTC

ByBenjamin P. Casella, OD, FAAO

January 15th 2021

Dr. Alexander, chair of the Alliance for Patient Safety, discusses recent changes from the FTC on contact lenses.

New COVID-19 stimulus bill info for ODs

ByChris Wroten, OD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director

January 15th 2021

Chris Wroten, OD covers how the recent COVID-19 stimulus bill affects ODs

Video: Optometry Times® news summary 12/31/2020

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director

December 31st 2020

Optometry news updates

Look back at contact lenses in 2020

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Benjamin P. Casella, OD, FAAO,Brooke Henson, Editor

December 17th 2020

Dr. Casella and Gretchyn cover new contact lens technology, specialty lenses, myopia and more.

Emerging treatment options for DR/DME

ByA. Paul Chous, OD, MA, FAAO,Steven Ferrucci, OD, FAAO

December 1st 2020

COVID-19 impact on management of DR/DME

ByA. Paul Chous, OD, MA, FAAO,Steven Ferrucci, OD, FAAO

December 1st 2020

DR/DME treatment options

ByA. Paul Chous, OD, MA, FAAO,Steven Ferrucci, OD, FAAO

December 1st 2020

ADA guidelines for managing DR/DME

ByA. Paul Chous, OD, MA, FAAO,Steven Ferrucci, OD, FAAO

December 1st 2020

Diabetes management challenges

ByA. Paul Chous, OD, MA, FAAO,Steven Ferrucci, OD, FAAO

December 1st 2020

Diabetes management: OD and MD communication

ByA. Paul Chous, OD, MA, FAAO,Steven Ferrucci, OD, FAAO

December 1st 2020

Optimize diabetes health management

ByA. Paul Chous, OD, MA, FAAO,Steven Ferrucci, OD, FAAO

December 1st 2020

Using OCT-A for patients with diabetes

ByA. Paul Chous, OD, MA, FAAO,Steven Ferrucci, OD, FAAO

December 1st 2020

Diabetic Retinopathy imaging

ByA. Paul Chous, OD, MA, FAAO,Steven Ferrucci, OD, FAAO

December 1st 2020

Updates in diabetic macular edema, diabetic retinopathy

ByA. Paul Chous, OD, MA, FAAO,Steven Ferrucci, OD, FAAO

December 1st 2020

Novel agents in the pipeline for DED

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Agents in the pipeline for DED

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Overlapping diseases and COVID-19's impact

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Counseling and formulary concerns for DED therapies

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Challenges in the management of DED

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Treatments for aqueous dry eye

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Crystal Brimer, OD, FAAO, shares some in-office procedures for dry eye and the patient resistance with high cost.

In-office procedures and patient resistance for DED treatments

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Crystal Brimer, OD, FAAO, identifies the preferred treatment options for meibomian gland dysfunction.

How to treat meibomian gland dysfunction

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Eric Donnenfeld, MD, and Marguerite McDonald, MD, discuss the role of nutritional supplements as well as antibiotics in dry eye management.

The role of nutritional supplements and antibiotics in DED

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

November 18th 2020

Corticosteroids and Immunomodulators for the treatment of dry eye

ByBrooke Henson, Editor,Tracy Schroeder Swartz, OD, MS, FAAO,Marguerite McDonald, MD,Eric Donnenfeld, MD,Crystal Brimer, OD, FAAO

Videos

Dr. Ben Casella muses on COVID-19 and vaccine

Celebrate World Glaucoma Week March 7-13, 2021

Optometry Times® news summary 2/28/2021

Looking ahead to 2021 optometry meetings

Optometry Times® news summary 2/7/2021

Optometry Times® news summary 1/17/2021

Alliance for Patient Safety chair talks contact lenses and the FTC

New COVID-19 stimulus bill info for ODs

Video: Optometry Times® news summary 12/31/2020

Look back at contact lenses in 2020

Emerging treatment options for DR/DME

COVID-19 impact on management of DR/DME

DR/DME treatment options

ADA guidelines for managing DR/DME

Diabetes management challenges

Diabetes management: OD and MD communication

Optimize diabetes health management

Using OCT-A for patients with diabetes

Diabetic Retinopathy imaging

Updates in diabetic macular edema, diabetic retinopathy

Novel agents in the pipeline for DED

Agents in the pipeline for DED

Overlapping diseases and COVID-19's impact

Counseling and formulary concerns for DED therapies

Challenges in the management of DED

Treatments for aqueous dry eye

In-office procedures and patient resistance for DED treatments

How to treat meibomian gland dysfunction

The role of nutritional supplements and antibiotics in DED

Corticosteroids and Immunomodulators for the treatment of dry eye

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Exercise for the prevention and mitigation of eye disease

Hybrid AI model distinguishes keratoconus from healthy eyes with 90% accuracy

Outlook Therapeutics resubmits BLA for bevacizumab-vikg (ONS-5010/Lytenava)